These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24635692)
21. Longitudinal prescribing patterns for psychoactive medications in community-based individuals with developmental disabilities: utilization of pharmacy records. Lott IT; McGregor M; Engelman L; Touchette P; Tournay A; Sandman C; Fernandez G; Plon L; Walsh D J Intellect Disabil Res; 2004 Sep; 48(Pt 6):563-71. PubMed ID: 15312057 [TBL] [Abstract][Full Text] [Related]
22. What Matters in Population Health and How We Count It Among People With Intellectual and Developmental Disabilities. Havercamp SM; Krahn GL Intellect Dev Disabil; 2019 Oct; 57(5):347-356. PubMed ID: 31568741 [TBL] [Abstract][Full Text] [Related]
23. Are cervical and breast cancer screening programmes equitable? The case of women with intellectual and developmental disabilities. Cobigo V; Ouellette-Kuntz H; Balogh R; Leung F; Lin E; Lunsky Y J Intellect Disabil Res; 2013 May; 57(5):478-88. PubMed ID: 23506206 [TBL] [Abstract][Full Text] [Related]
24. An Examination of Psychotropic Medication Side Effects: does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID? Mahan S; Holloway J; Bamburg JW; Hess JA; Fodstad JC; Matson JL Res Dev Disabil; 2010; 31(6):1561-9. PubMed ID: 20542660 [TBL] [Abstract][Full Text] [Related]
25. Research About Us, With Us: An Inclusive Research Case Study. Buck AS; Chapman R; Krahn GL; Brown C; Gertz B; Havercamp SM; Intellect Dev Disabil; 2024 Aug; 62(4):260-273. PubMed ID: 39069297 [TBL] [Abstract][Full Text] [Related]
26. Unlocking the Potential of State Level Data: Opportunities to Monitor Health and Related Outcomes in People With Intellectual and Developmental Disabilities. Bonardi A; Lauer E; Lulinski A; Fay ML; Morris A; Nygren MA; Krahn G Intellect Dev Disabil; 2019 Oct; 57(5):390-404. PubMed ID: 31568734 [TBL] [Abstract][Full Text] [Related]
27. The care burden of families with members having intellectual and developmental disorder: a review of the recent literature. Wang KY Curr Opin Psychiatry; 2012 Sep; 25(5):348-52. PubMed ID: 22744406 [TBL] [Abstract][Full Text] [Related]
28. Colonoscopy and colorectal cancer screening in adults with intellectual and developmental disabilities: review of a series of cases and recommendations for examination. Fischer LS; Becker A; Paraguya M; Chukwu C Intellect Dev Disabil; 2012 Oct; 50(5):383-90. PubMed ID: 23025640 [TBL] [Abstract][Full Text] [Related]
29. In Their Own Words: Perceptions and Experiences of Bullying Among Individuals With Intellectual and Developmental Disabilities. Griffin MM; Fisher MH; Lane LA; Morin L Intellect Dev Disabil; 2019 Feb; 57(1):66-74. PubMed ID: 30716007 [TBL] [Abstract][Full Text] [Related]
30. Long-term care of the aging population with intellectual and developmental disabilities. Kim NH; Hoyek GE; Chau D Clin Geriatr Med; 2011 May; 27(2):291-300. PubMed ID: 21641512 [TBL] [Abstract][Full Text] [Related]
31. Frequency of medication errors in primary care patients with polypharmacy. Koper D; Kamenski G; Flamm M; Böhmdorfer B; Sönnichsen A Fam Pract; 2013 Jun; 30(3):313-9. PubMed ID: 23132894 [TBL] [Abstract][Full Text] [Related]
32. Do people with intellectual disabilities understand their prescription medication? A scoping review. Smith MVA; Adams D; Carr C; Mengoni SE J Appl Res Intellect Disabil; 2019 Nov; 32(6):1375-1388. PubMed ID: 31338972 [TBL] [Abstract][Full Text] [Related]
33. Polypharmacy in older adults at home: what it is and what to do about it-implications for home healthcare and hospice, part 2. Riker GI; Setter SM Home Healthc Nurse; 2013 Feb; 31(2):65-77; quiz 78-9. PubMed ID: 23385171 [TBL] [Abstract][Full Text] [Related]
34. National trends in psychotropic medication polypharmacy in office-based psychiatry. Mojtabai R; Olfson M Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220 [TBL] [Abstract][Full Text] [Related]
35. A Call for Better Data on Prevalence and Health Surveillance of People With Intellectual and Developmental Disabilities. Krahn GL Intellect Dev Disabil; 2019 Oct; 57(5):357-375. PubMed ID: 31568742 [TBL] [Abstract][Full Text] [Related]
36. Growing health disparities for persons who are aging with intellectual and developmental disabilities: the social work linchpin. Robinson LM; Dauenhauer J; Bishop KM; Baxter J J Gerontol Soc Work; 2012; 55(2):175-90. PubMed ID: 22324333 [TBL] [Abstract][Full Text] [Related]
37. Families of individuals with intellectual and developmental disabilities: policy, funding, services, and experiences. Hewitt A; Agosta J; Heller T; Williams AC; Reinke J Intellect Dev Disabil; 2013 Oct; 51(5):349-59. PubMed ID: 24303822 [TBL] [Abstract][Full Text] [Related]
38. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Wastesson JW; Morin L; Tan ECK; Johnell K Expert Opin Drug Saf; 2018 Dec; 17(12):1185-1196. PubMed ID: 30540223 [TBL] [Abstract][Full Text] [Related]
39. Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review. Kelly N; Kilmartin A; Lannon K; Lee C; McLoughlin R; Mulvanny L; Mohamed O; Treacy M; Rossi K; O'Connell J Eur J Clin Pharmacol; 2022 Nov; 78(11):1711-1725. PubMed ID: 36042024 [TBL] [Abstract][Full Text] [Related]
40. Family quality of life of Australian families with a member with an intellectual/developmental disability. Rillotta F; Kirby N; Shearer J; Nettelbeck T J Intellect Disabil Res; 2012 Jan; 56(1):71-86. PubMed ID: 21883595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]